This Article Free upon publication Full Text Full Text (PDF) All Versions of this Article: 114/24/2710    most recent CIRCULATIONAHA.106.179568v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kavey, R.-E. W. Articles by Steinberger, J. Search for Related Content PubMed PubMed Citation Articles by Kavey, R.-E. W. Articles by Steinberger, J. Related Collections Lipid and lipoprotein metabolism Type 1 diabetes Type 2 diabetes Primary prevention Pathophysiology Risk Factors

(Circulation. 2006;114:2710-2738.)
© 2006 American Heart Association, Inc.

AHA Scientific Statements

Cardiovascular Risk Reduction in High-Risk Pediatric Patients

A Scientific Statement From the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: Endorsed by the American Academy of Pediatrics

Rae-Ellen W. Kavey, MD, MPH, FAHA, Chair; Vivek Allada, MD; Stephen R. Daniels, MD, PhD, FAHA; Laura L. Hayman, PhD, RN, FAHA; Brian W. McCrindle, MD, MPH; Jane W. Newburger, MD, MPH, FAHA; Rulan S. Parekh, MD, MS; Julia Steinberger, MD, MS

Although for most children the process of atherosclerosis is subclinical, dramatically accelerated atherosclerosis occurs in some pediatric disease states, with clinical coronary events occurring in childhood and very early adult life. As with most scientific statements about children and the future risk for cardiovascular disease, there are no randomized trials documenting the effects of risk reduction on hard clinical outcomes. A growing body of literature, however, identifies the importance of premature cardiovascular disease in the course of certain pediatric diagnoses and addresses the response to risk factor reduction. For this scientific statement, a panel of experts reviewed what is known about very premature cardiovascular disease in 8 high-risk pediatric diagnoses and, from the science base, developed practical recommendations for management of cardiovascular risk.

Key Words: AHA Scientific Statements • atherosclerosis • cardiovascular diseases • risk factors • prevention • pediatrics

This article has been cited by other articles:

				S. K. Kumanyika, E. Obarzanek, N. Stettler, R. Bell, A. E. Field, S. P. Fortmann, B. A. Franklin, M. W. Gillman, C. E. Lewis, W. C. Poston II, et al. Population-Based Prevention of Obesity: The Need for Comprehensive Promotion of Healthful Eating, Physical Activity, and Energy Balance: A Scientific Statement From American Heart Association Council on Epidemiology and Prevention, Interdisciplinary Committee for Prevention (Formerly the Expert Panel on Population and Prevention Science) Circulation, July 22, 2008; 118(4): 428 - 464. [Abstract] [Full Text] [PDF]

				P. O. Kwiterovich Cut Points for Lipids and Lipoproteins in Children and Adolescents: Should They Be Reassessed? Clin. Chem., July 1, 2008; 54(7): 1113 - 1115. [Full Text] [PDF]

				S. R. Daniels, F. R. Greer, and and the Committee on Nutrition Lipid Screening and Cardiovascular Health in Childhood Pediatrics, July 1, 2008; 122(1): 198 - 208. [Abstract] [Full Text] [PDF]

				J. Steinberger and A. S. Kelly Challenges of Existing Pediatric Dyslipidemia Guidelines: Call for Reappraisal Circulation, January 1, 2008; 117(1): 9 - 10. [Full Text] [PDF]

				American Diabetes Association Standards of Medical Care in Diabetes--2008 Diabetes Care, January 1, 2008; 31(Supplement_1): S12 - S54. [Full Text] [PDF]

				R. R. Rodriguez, R. A. Gomez-Diaz, J. T. Haj, F. J. A. Garnica, E. R. Soriano, E. N. Meguro, C. A. Aguilar-Salinas, and N. H. Wacher Carotid Intima-Media Thickness in Pediatric Type 1 Diabetic Patients Diabetes Care, October 1, 2007; 30(10): 2599 - 2602. [Abstract] [Full Text] [PDF]

				S. Ardoin, C. Sandborg, and L. Schanberg Review: Management of dyslipidemia in children and adolescents with systemic lupus erythematosus Lupus, August 1, 2007; 16(8): 618 - 626. [Abstract] [PDF]

				B. Ranchin and S. Fargue Review: New treatment strategies for proliferative lupus nephritis: keep children in mind! Lupus, August 1, 2007; 16(8): 684 - 691. [Abstract] [PDF]

				H.J. Avis, M.N. Vissers, E.A. Stein, F.A. Wijburg, M.D. Trip, J.J.P. Kastelein, and B.A. Hutten A Systematic Review and Meta-Analysis of Statin Therapy in Children With Familial Hypercholesterolemia Arterioscler. Thromb. Vasc. Biol., August 1, 2007; 27(8): 1803 - 1810. [Abstract] [Full Text] [PDF]

				R. Kelishadi Childhood Overweight, Obesity, and the Metabolic Syndrome in Developing Countries Epidemiol. Rev., May 3, 2007; (2007) mxm003v1. [Abstract] [Full Text] [PDF]

				B. W. McCrindle and for the Writing Group Summary of the American Heart Association's Scientific Statement on Drug Therapy of High-Risk Lipid Abnormalities in Children and Adolescents Arterioscler. Thromb. Vasc. Biol., May 1, 2007; 27(5): 982 - 985. [Full Text] [PDF]

				R.-E. W. Kavey Academy endorses cardiovascular risk reduction statement AAP News, March 1, 2007; 28(3): 19 - 20. [Full Text] [PDF]